Intuitive Surgical, Inc. $ISRG Stock: VIRGINIA RETIREMENT SYSTEMS ET Al Increases Position

VIRGINIA RETIREMENT SYSTEMS ET Al increased its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 59.7% during the 3rd quarter, according to its most recent filing with the SEC. The institutional investor owned 57,480 shares of the medical equipment provider’s stock after acquiring an additional 21,480 shares during the period. VIRGINIA RETIREMENT SYSTEMS ET Al’s holdings in Intuitive Surgical were worth $23,373,000 at the end of the most recent reporting period.

Several other large investors also recently bought and sold shares of the company. North Point Portfolio Managers Corp OH purchased a new stake in shares of Intuitive Surgical during the third quarter valued at approximately $27,000. John Boyer Inc. purchased a new stake in Intuitive Surgical during the 3rd quarter worth $27,000. Compass Wealth Management LLC purchased a new stake in Intuitive Surgical during the 3rd quarter worth $29,000. Main Street Group LTD purchased a new stake in Intuitive Surgical during the 1st quarter worth $30,000. Finally, Compass Financial Management LLC acquired a new position in Intuitive Surgical in the 2nd quarter worth $30,000. Institutional investors and hedge funds own 83.64% of the company’s stock.

Intuitive Surgical Price Performance

Shares of NASDAQ:ISRG opened at $432.01 on Friday. Intuitive Surgical, Inc. has a 12 month low of $328.57 and a 12 month high of $603.88. The stock has a market cap of $149.75 billion, a price-to-earnings ratio of 52.24, a PEG ratio of 2.98 and a beta of 1.46. The stock’s 50 day moving average price is $401.54 and its 200 day moving average price is $434.05.

Intuitive Surgical (NASDAQ:ISRG) last released its earnings results on Tuesday, October 20th. The medical equipment provider reported $3.00 EPS for the quarter, topping analysts’ consensus estimates of $2.65 by $0.35. Intuitive Surgical had a net margin of 25.54% and a return on equity of 18.17%. The business had revenue of $3.05 billion for the quarter, compared to the consensus estimate of $2.91 billion. During the same period in the previous year, the firm earned $2.40 EPS. The business’s revenue for the quarter was up 21.7% on a year-over-year basis. On average, sell-side analysts expect that Intuitive Surgical, Inc. will post 9.37 EPS for the current year.

Insiders Place Their Bets

In other Intuitive Surgical news, Director Craig Barratt sold 1,150 shares of Intuitive Surgical stock in a transaction on Friday, October 23rd. The shares were sold at an average price of $443.80, for a total transaction of $510,370.00. Following the completion of the sale, the director owned 1,150 shares of the company’s stock, valued at $510,370. This trade represents a 50.00% decrease in their position. The sale was disclosed in a filing with the SEC, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, VP Fredrik Widman sold 4,047 shares of the business’s stock in a transaction dated Friday, October 23rd. The shares were sold at an average price of $453.21, for a total value of $1,834,140.87. Following the completion of the transaction, the vice president owned 1,026 shares in the company, valued at $464,993.46. This trade represents a 79.78% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold 38,778 shares of company stock valued at $16,814,967 over the last ninety days. Insiders own 0.60% of the company’s stock.

Analyst Upgrades and Downgrades

ISRG has been the subject of several research analyst reports. BTIG Research reiterated a “buy” rating and set a $454.00 target price on shares of Intuitive Surgical in a research note on Wednesday, October 21st. Piper Sandler restated an “overweight” rating on shares of Intuitive Surgical in a research note on Friday, August 21st. Zacks Research upgraded Intuitive Surgical from a “hold” rating to a “strong-buy” rating in a research note on Thursday, October 22nd. Oppenheimer restated an “outperform” rating and set a $500.00 price objective on shares of Intuitive Surgical in a research note on Wednesday, October 21st. Finally, Truist Financial dropped their target price on Intuitive Surgical from $580.00 to $510.00 and set a “buy” rating on the stock in a research report on Thursday, July 16th. One research analyst has rated the stock with a Strong Buy rating, twenty-three have given a Buy rating, five have given a Hold rating and one has given a Sell rating to the stock. According to MarketBeat.com, Intuitive Surgical has an average rating of “Moderate Buy” and an average price target of $493.54.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops and manufactures robotic-assisted systems and related technologies for minimally invasive surgery. Its products are designed to help surgeons perform procedures through small incisions while providing enhanced visualization, precision and control. The company’s primary platform is the da Vinci Surgical System, which is used across a range of specialties, including urology, gynecology, general surgery, cardiothoracic surgery and other procedures.

The company also offers the Ion endoluminal system, which is designed to support minimally invasive lung biopsy procedures.